{ "cik": 875045, "cik_padded": "0000875045", "entityName": "BIOGEN INC.", "fiscal_years": [ { "accn": "0000875045-26-000013", "filed": "2026-02-06", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 153800000.0, "eps_diluted": 8.79, "free_cash_flow": 2050800000.0, "net_income": 1292900000.0, "operating_cash_flow": 2204600000.0, "revenue": 9890600000.0, "stockholders_equity": 18256800000.0, "total_assets": 29439500000.0, "total_liabilities": 11182700000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6125224573857412, "net_margin": 0.13072007764948537, "revenue_growth_yoy": 0.0221891503632737, "roa_avg2y": 0.04497919594773243, "roa_period_end": 0.04391718609351382, "roe_avg2y": 0.0739374599688901, "roe_period_end": 0.0708174488409798 } }, { "accn": "0000875045-26-000013", "filed": "2026-02-06", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 153700000.0, "eps_diluted": 11.18, "free_cash_flow": 2721800000.0, "net_income": 1632200000.0, "operating_cash_flow": 2875500000.0, "revenue": 9675900000.0, "stockholders_equity": 16716000000.0, "total_assets": 28049300000.0, "total_liabilities": 11333300000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6779911462072266, "net_margin": 0.16868715054930292, "revenue_growth_yoy": -0.016236935214933506, "roa_avg2y": 0.05946722871856903, "roa_period_end": 0.0581904004734521, "roe_avg2y": 0.10358110637973816, "roe_period_end": 0.09764297678870543 } }, { "accn": "0000875045-26-000013", "filed": "2026-02-06", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 277000000.0, "eps_diluted": 7.97, "free_cash_flow": 1270200000.0, "net_income": 1161100000.0, "operating_cash_flow": 1547200000.0, "revenue": 9835600000.0, "stockholders_equity": 14799400000.0, "total_assets": 26844800000.0, "total_liabilities": 12045400000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8139113747854643, "net_margin": 0.11805075440237504, "revenue_growth_yoy": -0.033204238504334835, "roa_avg2y": 0.04517995521304931, "roa_period_end": 0.04325232447252354, "roe_avg2y": 0.08238315867148199, "roe_period_end": 0.07845588334662217 } }, { "accn": "0000875045-26-000013", "filed": "2026-02-06", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 750000000.0, "capex": 240300000.0, "eps_diluted": 20.87, "free_cash_flow": 1144000000.0, "net_income": 3046900000.0, "operating_cash_flow": 1384300000.0, "revenue": 10173400000.0, "stockholders_equity": 13388400000.0, "total_assets": 24554100000.0, "total_liabilities": 11165700000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8339831495921842, "net_margin": 0.29949672675801603, "revenue_growth_yoy": -0.07360426892011256, "roa_avg2y": 0.1258233294928497, "roa_period_end": 0.1240892559694715, "roe_avg2y": 0.2502782557981937, "roe_period_end": 0.22757760449344208 } }, { "accn": "0000875045-25-000009", "filed": "2025-02-12", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1800000000.0, "capex": 258100000.0, "eps_diluted": 10.4, "free_cash_flow": 3381800000.0, "net_income": 1556100000.0, "operating_cash_flow": 3639900000.0, "revenue": 10981700000.0, "stockholders_equity": 10959700000.0, "total_assets": 23877300000.0, "total_liabilities": 12917600000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1786454008777612, "net_margin": 0.14169937259258586, "revenue_growth_yoy": -0.18318878955119527, "roa_avg2y": 0.06417410023878159, "roa_period_end": 0.06517068512771544, "roe_avg2y": 0.14377846972622865, "roe_period_end": 0.14198381342554997 } }, { "accn": "0000875045-24-000009", "filed": "2024-02-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 6679100000.0, "capex": 424800000.0, "eps_diluted": 24.8, "free_cash_flow": 3805000000.0, "net_income": 4000600000.0, "operating_cash_flow": 4229800000.0, "revenue": 13444600000.0, "stockholders_equity": 10686100000.0, "total_assets": 24618900000.0, "total_liabilities": 13932800000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3038245945667737, "net_margin": 0.29756184639185995, "revenue_growth_yoy": -0.06491212207624202, "roa_avg2y": 0.1543048452168815, "roa_period_end": 0.16250116780197327, "roe_avg2y": 0.3330336480029303, "roe_period_end": 0.37437418702800834 } }, { "accn": "0000875045-23-000009", "filed": "2023-02-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 5868300000.0, "capex": 514500000.0, "eps_diluted": 31.42, "free_cash_flow": 6564100000.0, "net_income": 5888500000.0, "operating_cash_flow": 7078600000.0, "revenue": 14377900000.0, "stockholders_equity": 13339100000.0, "total_assets": 27234300000.0, "total_liabilities": 13895200000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0416894693045258, "net_margin": 0.4095521599120873, "revenue_growth_yoy": 0.0687584089675832, "roa_avg2y": 0.22422472355073567, "roa_period_end": 0.21621631545514297, "roe_avg2y": 0.44659413667441517, "roe_period_end": 0.4414465743565908 } }, { "accn": "0000875045-22-000007", "filed": "2022-02-03", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 4352600000.0, "capex": 770600000.0, "eps_diluted": 21.58, "free_cash_flow": 5417100000.0, "net_income": 4430700000.0, "operating_cash_flow": 6187700000.0, "revenue": 13452900000.0, "stockholders_equity": 13031600000.0, "total_assets": 25288900000.0, "total_liabilities": 12257300000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9405828908192394, "net_margin": 0.3293490622839685, "revenue_growth_yoy": 0.09605748784005085, "roa_avg2y": 0.18106106269730188, "roa_period_end": 0.17520335008640153, "roe_avg2y": 0.3457473165897377, "roe_period_end": 0.3399966235918843 } }, { "accn": "0000875045-21-000010", "filed": "2021-02-03", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1365400000.0, "capex": 867400000.0, "eps_diluted": 11.92, "free_cash_flow": 3683600000.0, "net_income": 2539100000.0, "operating_cash_flow": 4551000000.0, "revenue": 12273900000.0, "stockholders_equity": 12598100000.0, "total_assets": 23652600000.0, "total_liabilities": 11054500000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8774735872869719, "net_margin": 0.20686986206503233, "revenue_growth_yoy": 0.07206868842149396, "roa_avg2y": 0.10913959775969602, "roa_period_end": 0.10734972053812265, "roe_avg2y": 0.20537313915726724, "roe_period_end": 0.20154626491296304 } }, { "accn": "0000875045-20-000005", "filed": "2020-02-06", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1000000000.0, "capex": 616100000.0, "eps_diluted": 16.93, "free_cash_flow": 3971100000.0, "net_income": 3702800000.0, "operating_cash_flow": 4587200000.0, "revenue": 11448800000.0, "stockholders_equity": 12128600000.0, "total_assets": 22876800000.0, "total_liabilities": 10748200000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8861863694078459, "net_margin": 0.32342254210048216, "roa_period_end": 0.16185830186040007, "roe_period_end": 0.3052949227445872 } }, { "accn": "0000875045-18-000005", "filed": "2018-02-01", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 5000000000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0000875045-26-000013", "filed": "2026-02-06", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000875045.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000875045.json" }, "ticker": "BIIB" }